Emergent BioSolutions Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Emergent BioSolutions Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Emergent BioSolutions Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $13.3M, a 18.8% increase year-over-year.
  • Emergent BioSolutions Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $8.9M, a 84.1% decline year-over-year.
  • Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2023 was $29.3M.
  • Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2022 was -$7.4M, a 109% decline from 2021.
  • Emergent BioSolutions Inc. annual Income Tax Expense (Benefit) for 2021 was $83.7M, a 21.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.9M $13.3M +$2.1M +18.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.8M $3.1M -$22.5M -87.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $29.3M -$5M -$4.2M -525% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $33.5M -$2.5M -$22.4M -113% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $55.9M $11.2M +$37.6M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $18.3M $25.6M +$25.7M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$7.4M -$800K -$79.2M -101% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $71.8M $19.9M +$32.7M Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $39.1M -$26.4M -$29M -1115% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $68.1M -$100K -$15.6M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $83.7M $78.4M +$7M +9.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 $76.7M -$12.8M -$28.3M -183% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $105M $2.6M -$25.4M -90.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $130M $15.5M +$24.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $106M $71.4M +$46.8M +190% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
Q3 2020 $59.3M $15.5M -$200K -1.27% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $59.5M $28M +$33.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $25.9M -$8.8M +$3M +25.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $22.9M $24.6M +$17.6M +251% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $5.3M $15.7M +$15.1M +2517% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$9.8M -$5.6M -$21.3M -136% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $11.5M -$11.8M -$7.3M -162% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $18.8M $7M -$11M -61.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $29.8M $600K -$12.2M -95.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $41.9M $15.7M +$13.6M +646% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $28.3M -$4.5M -$7.66M -242% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $36M $18M +$1.14M +6.74% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $34.9M $12.8M -$402K -3.05% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $35.3M $2.11M +$3.37M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $31.9M $3.16M -$4.81M -60.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $36.7M $16.8M -$10.2M -37.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $46.9M $13.2M -$6.89M -34.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $53.8M -$1.27M -$6.77M -123% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $60.5M $7.97M +$16.2M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $44.3M $27M -$789K -2.84% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 $45.1M $20.1M +$12.2M +155% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $32.9M $5.5M +$3.04M +123% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $29.9M -$8.27M -$64K -0.78% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $29.9M $27.8M +$19.4M +229% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $10.6M $7.87M +$3.07M +63.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $7.5M $2.47M -$1.92M -43.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $9.42M -$8.21M -$3.69M -81.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $13.1M $8.44M -$842K -9.07% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $14M $4.8M +$566K +13.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $13.4M $4.38M +$338K +8.36% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $13M -$4.52M -$876K -24.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $13.9M $9.28M -$9.58M -50.8% Oct 1, 2012 Dec 31, 2012 10-K/A 2015-03-09
Q3 2012 $23.5M $4.24M +$2.63M +164% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $20.9M $4.04M -$3.62M -47.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $24.5M -$3.64M +$8.66M +70.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $15.8M $18.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 $1.6M -$6.09M -79.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $7.66M +$1.91M +33.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$12.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $7.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $5.76M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.